We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-14.86%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$134B
AUM Growth
-$30.1B
Cap. Flow
-$1.57B
Cap. Flow %
-1.17%
Top 10 Hldgs %
29.15%
Holding
6,955
New
507
Increased
2,096
Reduced
2,889
Closed
579

Sector Composition

Rank Sector Weight
1 Technology 10.07%
2 Financials 5.69%
3 Healthcare 5.49%
4 Consumer Discretionary 4.41%
5 Industrials 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCAW
4751
CALL
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$24K ﹤0.01%
150,001
FXLV
4752
DELISTED
F45 Training Holdings Inc.
FXLV
$24K ﹤0.01%
6,137
+3,695
+151% +$27K
IRNT
4753
DELISTED
IronNet, Inc.
IRNT
$24K ﹤0.01%
10,666
-1,368
-11% -$3.86K
GRNA
4754
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$24K ﹤0.01%
10,905
+5,189
+91% +$36K
PRVB
4755
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$24K ﹤0.01%
6,209
-5,236
-46% -$24.8K
CINC
4756
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$24K ﹤0.01%
1,279
+259
+25% +$4.96K
PIPP.WS
4757
CALL
DELISTED
Pine Island Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PIPP.WS
$24K ﹤0.01%
92,342
USAK
4758
DELISTED
USA Truck Inc
USAK
$24K ﹤0.01%
755
+225
+42% +$3.88K
ARBE icon
4759
Arbe Robotics
ARBE
$73.3M
$23K ﹤0.01%
4,199
-1,335
-24% -$9.07K
AXGN icon
4760
Axogen
AXGN
$2.2B
$23K ﹤0.01%
2,761
+113
+4% +$966
SRTA
4761
Strata Critical Medical Inc
SRTA
$421M
$23K ﹤0.01%
5,067
-7,154
-59% -$51.6K
BLFY
4762
DELISTED
Blue Foundry Bancorp
BLFY
$23K ﹤0.01%
1,934
+588
+44% +$7.26K
BMEA icon
4763
Biomea Fusion
BMEA
$88.2M
$23K ﹤0.01%
1,891
-332
-15% -$1.94K
CDC icon
4764
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$750M
$23K ﹤0.01%
+346
New +$24.2K
CIVB icon
4765
Civista Bancshares
CIVB
$608M
$23K ﹤0.01%
1,063
+431
+68% +$9.34K
EVCM icon
4766
EverCommerce
EVCM
$2.14B
$23K ﹤0.01%
2,517
+1,387
+123% +$15K
FEAM icon
4767
5E Advanced Materials
FEAM
$43.6M
$23K ﹤0.01%
+82
New +$42.7K
GGME icon
4768
Invesco Next Gen Media and Gaming ETF
GGME
$44.7M
$23K ﹤0.01%
681
IGMS
4769
DELISTED
IGM Biosciences
IGMS
$23K ﹤0.01%
1,315
-1,379
-51% -$24.6K
MVBF icon
4770
MVB Financial
MVBF
$400M
$23K ﹤0.01%
743
+304
+69% +$11.5K
PERI icon
4771
Perion Network
PERI
$380M
$23K ﹤0.01%
1,276
+450
+54% +$9.33K
PTH icon
4772
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$217M
$23K ﹤0.01%
600
PTNQ icon
4773
Pacer Trendpilot 100 ETF
PTNQ
$1.16B
$23K ﹤0.01%
463
+25
+6% +$1.29K
REAL icon
4774
The RealReal
REAL
$1.41B
$23K ﹤0.01%
9,584
+2,673
+39% +$11.9K
SPXL icon
4775
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.27B
$23K ﹤0.01%
351
+291
+485% +$25.5K

Similar funds

Citigroup's Q2 2022 Portfolio in Review

As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
  • Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
  • Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
  • Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
  • Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
  • Citigroup opened 507 new positions and closed 579 in Q2 2022.
  • Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.